Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Taysha Gene Therapies (TSHA) Prepaid Assets (2022 - 2025)

Taysha Gene Therapies' Prepaid Assets history spans 4 years, with the latest figure at $232000.0 for Q1 2025.

  • For Q1 2025, Prepaid Assets changed N/A year-over-year to $232000.0; the TTM value through Mar 2025 reached $232000.0, changed N/A, while the annual FY2022 figure was $388000.0, N/A changed from the prior year.
  • Prepaid Assets for Q1 2025 was $232000.0 at Taysha Gene Therapies, up from $206000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $5.5 million in Q3 2023 and bottomed at $206000.0 in Q2 2024.
  • The 4-year median for Prepaid Assets is $376500.0 (2022), against an average of $1.2 million.
  • The largest YoY upside for Prepaid Assets was 1355.0% in 2023 against a maximum downside of 1355.0% in 2023.
  • A 4-year view of Prepaid Assets shows it stood at $388000.0 in 2022, then surged by 1325.0% to $5.5 million in 2023, then crashed by 96.27% to $206000.0 in 2024, then increased by 12.62% to $232000.0 in 2025.
  • Per Business Quant, the three most recent readings for TSHA's Prepaid Assets are $232000.0 (Q1 2025), $206000.0 (Q2 2024), and $5.5 million (Q3 2023).